Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Varian Medical SystemsSonovaMasimoGetingeLivaNova
SymbolNYSE:VAROTCMKTS:SONVYNASDAQ:MASIOTCMKTS:GNGBYNASDAQ:LIVN
Price Information
Current Price$177.07$57.77$245.74$30.56$81.34
52 Week RangeHoldHoldBuyBuyHold
MarketRank™
Overall Score1.30.91.60.61.5
Analysis Score0.80.02.40.01.2
Community Score2.61.92.62.32.7
Dividend Score0.00.00.00.00.0
Ownership Score1.70.01.70.01.7
Earnings & Valuation Score1.32.51.30.61.9
Analyst Ratings
Consensus RecommendationHoldHoldBuyBuyHold
Consensus Price Target$159.36N/A$272.20N/A$69.33
% Upside from Price Target-10.00% downsideN/A10.77% upsideN/A-14.76% downside
Trade Information
Market Cap$16.26 billion$18.60 billion$13.58 billion$7.77 billion$3.96 billion
Beta1.060.70.870.830.8
Average Volume746,78021,845329,2331,857494,533
Sales & Book Value
Annual Revenue$3.17 billion$2.96 billion$937.84 million$2.81 billion$1.08 billion
Price / Sales5.136.2914.482.763.65
Cashflow$5.07 per share$2.41 per share$3.46 per share$2.08 per share$6.95 per share
Price / Cash34.9423.9371.0414.6911.70
Book Value$22.92 per share$6.35 per share$21.90 per share$8.15 per share$28.59 per share
Price / Book7.739.1011.223.752.85
Profitability
Net Income$269.20 million$489.96 million$196.22 million$129.29 million$-155,180,000.00
EPS$3.91$1.49$3.22N/A$3.08
Trailing P/E Ratio60.4338.7763.8325.25N/A
Forward P/E Ratio30.1128.3265.7144.21
P/E GrowthN/AN/A3.79N/AN/A
Net Margins8.50%N/A20.30%10.51%-21.88%
Return on Equity (ROE)18.45%N/A15.75%17.30%5.55%
Return on Assets (ROA)8.08%N/A13.12%7.90%3.07%
Dividend
Annual PayoutN/AN/AN/A$0.11N/A
Dividend YieldN/AN/AN/A0.36%N/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.69%N/A0.50%0.47%
Current Ratio1.40%2.57%4.98%1.79%2.39%
Quick Ratio1.13%2.26%4.10%1.25%1.76%
Ownership Information
Institutional Ownership Percentage86.96%1.12%81.64%0.02%89.10%
Insider Ownership Percentage0.78%N/A11.50%N/A0.48%
Miscellaneous
Employees10,00014,3492,00010,4974,000
Shares Outstanding91.84 million321.99 million55.27 million254.15 million48.66 million
Next Earnings Date5/3/2021 (Estimated)5/18/2021 (Estimated)4/27/2021 (Confirmed)4/20/2021 (Estimated)4/28/2021 (Confirmed)
OptionableOptionableNot OptionableOptionableNot OptionableOptionable
SourceHeadline
Global Oxygenator Market 2021 Top Key Players – Medtronic, Terumo, Sorin Group (LivaNova), EUROSETS Srl, Chalice Medical Ltd - Los Hijos de la MalincheGlobal Oxygenator Market 2021 Top Key Players – Medtronic, Terumo, Sorin Group (LivaNova), EUROSETS Srl, Chalice Medical Ltd - Los Hijos de la Malinche
loshijosdelamalinche.com - April 15 at 8:15 AM
Global Epilepsy Market 2021 Overview, Opportunities, In-Depth Analysis by 2025 : LivaNova, GW Pharmaceuticals, Johnson & Johnson Services, GlaxoSmithKline PLC, Pfizer, Eisai, NeuroPace - Los Hijos de la MalincheGlobal Epilepsy Market 2021 Overview, Opportunities, In-Depth Analysis by 2025 : LivaNova, GW Pharmaceuticals, Johnson & Johnson Services, GlaxoSmithKline PLC, Pfizer, Eisai, NeuroPace - Los Hijos de la Malinche
loshijosdelamalinche.com - April 15 at 3:15 AM
Is LIVN Stock A Buy or Sell? - Yahoo FinanceIs LIVN Stock A Buy or Sell? - Yahoo Finance
finance.yahoo.com - April 14 at 10:14 PM
LivaNova (NASDAQ:LIVN) Reaches New 1-Year High After Analyst UpgradeLivaNova (NASDAQ:LIVN) Reaches New 1-Year High After Analyst Upgrade
americanbankingnews.com - April 14 at 12:22 PM
Is LIVN Stock A Buy or Sell?Is LIVN Stock A Buy or Sell?
finance.yahoo.com - April 14 at 12:14 PM
3rd Cir. Reinstates LivaNova 3T Heater-Cooler System Action - HarrisMartin Publishing3rd Cir. Reinstates LivaNova 3T Heater-Cooler System Action - HarrisMartin Publishing
harrismartin.com - April 13 at 4:12 PM
Piper Sandler Boosts LivaNova (NASDAQ:LIVN) Price Target to $92.00Piper Sandler Boosts LivaNova (NASDAQ:LIVN) Price Target to $92.00
americanbankingnews.com - April 13 at 9:16 AM
LivaNova (NASDAQ:LIVN) Given New $92.00 Price Target at Piper SandlerLivaNova (NASDAQ:LIVN) Given New $92.00 Price Target at Piper Sandler
marketbeat.com - April 13 at 7:29 AM
$232.08 Million in Sales Expected for LivaNova PLC (NASDAQ:LIVN) This Quarter$232.08 Million in Sales Expected for LivaNova PLC (NASDAQ:LIVN) This Quarter
americanbankingnews.com - April 13 at 3:16 AM
LivaNova PLC (LIVN) Stock: What Does the Chart Say Monday? - InvestorsObserverLivaNova PLC (LIVN) Stock: What Does the Chart Say Monday? - InvestorsObserver
investorsobserver.com - April 12 at 5:49 PM
Heater-Cooler suit against LivaNova revived - Mass DeviceHeater-Cooler suit against LivaNova revived - Mass Device
massdevice.com - April 12 at 12:49 PM
Zacks: Analysts Expect LivaNova PLC (NASDAQ:LIVN) to Post $0.15 Earnings Per ShareZacks: Analysts Expect LivaNova PLC (NASDAQ:LIVN) to Post $0.15 Earnings Per Share
americanbankingnews.com - April 11 at 2:12 PM
Global Ventricular Assist Device Market Expected To Reach $ 2498.37 Million Growth By 2026||Evaheart, Inc., Jarvik Heart, Inc., Medtronic, Terumo Corporation, ReliantHeart Inc., Calon Cardio, LivaNova PLC – ROUGH Magazine - ROUGH MagazineGlobal Ventricular Assist Device Market Expected To Reach $ 2498.37 Million Growth By 2026||Evaheart, Inc., Jarvik Heart, Inc., Medtronic, Terumo Corporation, ReliantHeart Inc., Calon Cardio, LivaNova PLC – ROUGH Magazine - ROUGH Magazine
rough.asia - April 9 at 7:50 PM
3rd Circ. Revives LivaNova Bacteria Exposure Suit - Law3603rd Circ. Revives LivaNova Bacteria Exposure Suit - Law360
law360.com - April 9 at 7:50 PM
LivaNova Heater-Cooler Patient Gets Infection Suit Reinstated - Bloomberg LawLivaNova Heater-Cooler Patient Gets Infection Suit Reinstated - Bloomberg Law
news.bloomberglaw.com - April 9 at 2:50 PM
Global Epilepsy Market 2021 SWOT Analysis – LivaNova, GW Pharmaceuticals, Johnson & Johnson Services, GlaxoSmithKline PLC, Pfizer, Eisai – ROUGH Magazine - ROUGH MagazineGlobal Epilepsy Market 2021 SWOT Analysis – LivaNova, GW Pharmaceuticals, Johnson & Johnson Services, GlaxoSmithKline PLC, Pfizer, Eisai – ROUGH Magazine - ROUGH Magazine
rough.asia - April 7 at 2:19 PM
Congestive Heart Failure Treatment Device Market 2021 Outlook By Micromed AS, LivaNova PLC, ABIOMED – The Market Eagle - The Market EagleCongestive Heart Failure Treatment Device Market 2021 Outlook By Micromed AS, LivaNova PLC, ABIOMED – The Market Eagle - The Market Eagle
themarketeagle.com - April 7 at 2:19 PM
Global Aortic Heart Valve Market 2021 Key Drivers – Edwards Lifesciences, Medtronic, Abbott, Livanova – ROUGH Magazine - ROUGH MagazineGlobal Aortic Heart Valve Market 2021 Key Drivers – Edwards Lifesciences, Medtronic, Abbott, Livanova – ROUGH Magazine - ROUGH Magazine
rough.asia - April 7 at 9:18 AM
Global Double Roller Pump Artificial Heart Lung Machine Market 2021 Industry Dynamics – LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group – ROUGH Magazine - ROUGH MagazineGlobal Double Roller Pump Artificial Heart Lung Machine Market 2021 Industry Dynamics – LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group – ROUGH Magazine - ROUGH Magazine
rough.asia - April 7 at 9:18 AM
Global Single Roller Pump Artificial Heart Lung Machine Market 2021 Key Drivers – LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group – ROUGH Magazine - ROUGH MagazineGlobal Single Roller Pump Artificial Heart Lung Machine Market 2021 Key Drivers – LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group – ROUGH Magazine - ROUGH Magazine
rough.asia - April 7 at 9:18 AM
Global Blood Pump-Gas Exchange System Market 2021 Key Drivers – LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group – ROUGH Magazine - ROUGH MagazineGlobal Blood Pump-Gas Exchange System Market 2021 Key Drivers – LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group – ROUGH Magazine - ROUGH Magazine
rough.asia - April 7 at 9:18 AM
Global Seizure Detection Devices Market Things to Focus on to Ensure Long-term Success | Medtronic PLC, - Global Banking And Finance ReviewGlobal Seizure Detection Devices Market Things to Focus on to Ensure Long-term Success | Medtronic PLC, - Global Banking And Finance Review
globalbankingandfinance.com - April 6 at 12:56 PM
Global Artificial Cardiopulmonary Machine Market 2021 SWOT Analysis – LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group – ROUGH Magazine - ROUGH MagazineGlobal Artificial Cardiopulmonary Machine Market 2021 SWOT Analysis – LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group – ROUGH Magazine - ROUGH Magazine
rough.asia - April 6 at 2:56 AM
Global Percutaneous Mechanical Circulatory Support Devices Market Ongoing Analysis 2021 – Medtronic, Abbott Laboratories, LivaNova – ROUGH Magazine - ROUGH MagazineGlobal Percutaneous Mechanical Circulatory Support Devices Market Ongoing Analysis 2021 – Medtronic, Abbott Laboratories, LivaNova – ROUGH Magazine - ROUGH Magazine
rough.asia - April 5 at 4:35 PM
Global Long-term Mechanical Circulatory Support Market Ongoing Analysis 2021 – Abbott Laboratories, LivaNova, Nipro Corporation – ROUGH Magazine - ROUGH MagazineGlobal Long-term Mechanical Circulatory Support Market Ongoing Analysis 2021 – Abbott Laboratories, LivaNova, Nipro Corporation – ROUGH Magazine - ROUGH Magazine
rough.asia - April 5 at 11:35 AM
Cardiac Monitoring Devices Market New Business Experts Ideas By Biotronik, Livanova, Biotelemetry, Schiller, iRhythm Technologies - Industry TodayCardiac Monitoring Devices Market New Business Experts Ideas By Biotronik, Livanova, Biotelemetry, Schiller, iRhythm Technologies - Industry Today
industrytoday.co.uk - April 5 at 6:35 AM
DateCompanyBrokerageAction
3/1/2021Varian Medical SystemsUBS GroupDowngrade
12/7/2020Varian Medical SystemsJefferies Financial GroupDowngrade
10/28/2020Varian Medical SystemsBarrington ResearchDowngrade
10/28/2020Varian Medical SystemsRobert W. BairdDowngrade
8/10/2020Varian Medical SystemsBTIG ResearchDowngrade
8/2/2020Varian Medical SystemsPiper SandlerDowngrade
3/24/2021SonovaJPMorgan Chase & Co.Reiterated Rating
2/18/2021SonovaExane BNP ParibasUpgrade
12/9/2020SonovaMorgan StanleyReiterated Rating
11/23/2020SonovaBerenberg BankReiterated Rating
11/17/2020SonovaCredit Suisse GroupReiterated Rating
10/8/2020SonovaCitigroupInitiated Coverage
9/29/2020SonovaDeutsche Bank AktiengesellschaftReiterated Rating
10/31/2019SonovaThe Goldman Sachs GroupDowngrade
1/29/2021MasimoRaymond JamesBoost Price Target
10/28/2020MasimoStifel NicolausBoost Price Target
10/6/2020MasimoNeedham & Company LLCReiterated Rating
12/17/2019MasimoPiper Jaffray CompaniesReiterated Rating
4/13/2021GetingeDNB MarketsUpgrade
3/11/2021GetingeSEB Equity ResearchUpgrade
3/11/2021GetingeSEB EquitiesUpgrade
9/9/2020GetingeBank of AmericaInitiated Coverage
4/30/2020LivaNovaCanaccord GenuityLower Price Target
(Data available from 4/17/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.